Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- FBRX
- Price
- 32.00
- Stock movement up
- +0.50 (1.59%)
- Company name
- Forte Biosciences Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 397.85M
- Ent value
- 317.43M
- Price/Sales
- 10469.77
- Price/Book
- 4.73
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 5.26%
- 1 year return (CAGR)
- 117.69%
- 3 year return (CAGR)
- -
- 5 year return (CAGR)
- -
- 10 year return (CAGR)
- -
Last updated: 2026-01-22
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
FBRX does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 10469.77 |
| Price to Book | 4.73 |
| EV to Sales | 8353.40 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 12.43M |
| EPS (TTM) | -2.91 |
| FCF per share (TTM) | -2.50 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 38.00K |
| Gross profit (TTM) | -55.00K |
| Operating income (TTM) | -53.44M |
| Net income (TTM) | -51.74M |
| EPS (TTM) | -2.91 |
| EPS (1y forward) | -3.33 |
Margins
Loading...
Margins data
| Gross margin (TTM) | -144.74% |
| Operating margin (TTM) | -140623.68% |
| Profit margin (TTM) | -136163.16% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 93.41M |
| Net receivables | 0.00 |
| Total current assets | 95.41M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 241.00K |
| Total assets | 97.09M |
| Accounts payable | 5.49M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 12.99M |
| Total liabilities | 12.99M |
| Shareholder's equity | 84.10M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -44.42M |
| Capital expenditures (TTM) | 147.00K |
| Free cash flow (TTM) | -44.57M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -61.53% |
| Return on Assets | -53.29% |
| Return on Invested Capital | -61.53% |
| Cash Return on Invested Capital | -53.00% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 31.45 |
| Daily high | 33.58 |
| Daily low | 31.28 |
| Daily Volume | 170K |
| All-time high | 6525.00 |
| 1y analyst estimate | 52.25 |
| Beta | 3.30 |
| EPS (TTM) | -2.91 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| FBRX | S&P500 | |
| Current price drop from All-time high | -99.51% | -0.89% |
| Highest price drop | -99.94% | -19.00% |
| Date of highest drop | 1 Nov 2024 | 8 Apr 2025 |
| Avg drop from high | -99.80% | -2.49% |
| Avg time to new high | - | 6 days |
| Max time to new high | 322 days | 89 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
397.85M
Marketcap category
Small-cap
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
Employees
16
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page